Sab Biotherapeutics, Inc. · NASDAQ:SABS

Ra Capital Management, L.P. reported a 9.90% stake in Sab Biotherapeutics, Inc. (Schedule 13D/A)

Event Mar 9, 2026 · Filed Mar 11, 2026

Ra Capital Management, L.P. reported a 9.90% stake in Sab Biotherapeutics, Inc., 5,166,424 shares, with active intent on Mar 9, 2026. Filed Mar 11, 2026 (Schedule 13D/A).

Stake
9.90%
Shares
5,166,424
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%5,166,424
Peter Kolchinsky9.90%5,166,424
Rajeev Shah9.90%5,166,424
RA Capital Healthcare Fund, L.P.9.90%5,166,424

Source

View original at SEC

Related